Zhejiang Xinguang Pharmaceutical Co., Ltd.

Zhejiang Xinguang Pharmaceutical Co., Ltd. saw a notable stock increase on July 13, 2026, reaching an intraday high amid a declining market. The company reported strong operational metrics, including record cash flow and reduced raw material costs, despite facing longer-term performance challenges. Its market capitalization is CNY 1,296 million.

Zhejiang Xinguang Pharmaceutical Co., Ltd. has experienced a recent evaluation adjustment due to shifts in its financial metrics and market standing. The company faces challenges in long-term growth, with declining net sales and operating profit, alongside low inventory turnover, indicating potential inefficiencies in management.

Zhejiang Xinguang Pharmaceutical Co., Ltd. saw a notable decline in its stock performance, with significant drops over the past week and month. The company, categorized as small-cap with a market capitalization of CNY 1,623 million, faces challenges in net sales growth and operating profit.